Methotrexate patient education: A quality improvement study

Arthritis and Rheumatism

Volumn 9, Issue 3, 1996, Pages 216-222

  Burma, Molly R ^a   Rachow, John W ^b   Kolluri, Sheela ^b   Saag, Kenneth G ^b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Arthritis; Methotrexate; Side effects

Indexed keywords

METHOTREXATE;

ADULT; AGED; ARTICLE; CONGENITAL MALFORMATION; CYTOPENIA; DRUG SAFETY; FEMALE; HUMAN; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATIENT EDUCATION; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; STOMATITIS;

EID: 84988285648     PISSN: 0004-3591     EISSN: 1529-0131     Source Type: Journal    
DOI: 10.1002/1529-0131(199606)9:3<216::AID-ANR1790090310>3.0.CO;2-5     Document Type: Article

References (26)

1. Gubner R, August S, Ginsberg V: Therapeutic suppression of tissue reactivity. II. Effect of aminopterm in rheumatoid arthritis and psoriasis. Am J Med Sci 221:176-182, 1951
2. Cash JM, Klippel JH: Second-line drug therapy for rheumatoid arthritis. N Engl J Med 330:1368-1375, 1994
3. Pincus T, Marcum SB, Callahan LF: Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone. J Rheumatol 19:1885-1894, 1992
4. Krall PL, Mazanec DJ, Wilke WS: Methotrexate for corticosteroid-resistant polymyalgia rheumatica and giant cell arteritis. Cleve Clin J Med 56:253-257, 1989
5. Rothenberg RJ, Graziano FM, Grandone JT, et al: The use of methotrexate in steroid-resistant systemic lupus erythematosus. Arthritis Rheum 31:612-615, 1988
6. Scully CJ, Anderson CJ, Cannon GLO: Long-term methotrexate therapy for rheumatoid arthritis. Semin Arthritis Rheum 20:317-331, 1991
7. Kremer JM, Phelps CT: Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis: update after a mean of 90 months. Arthritis Rheum 35:138-145, 1992
8. Kremer JM, Alarcón GS, Lightfoot RW Jr, Willkens RF, Furst DE, Williams HJ, Dent PB, Weinblatt ME: Methotrexate for rheumatoid arthritis: suggested guidelines for monitoring liver toxicity. Arthritis Rheum 37:316-328, 1994
9. Carroll GJ, Thomas R, Phatouros CC, Atchison MH, Leslie A-L, Cook NJ, D'Souza I: Incidence, prevalence and possible risk factors for pneumonitis in patients with rheumatoid arthritis receiving methotrexate. J Rheumatol 21:51-54, 1994
10. Hargreaves MR, Mowat AG, Benson MK: Acute pneumonitis associated with low-dose methotrexate treatment for rheumatoid arthritis: report of five cases and review of published reports. Thorax 47:628-633, 1992
11. Milunsky A, Graef JW, Gaynor MF: Methotrexate-induced congenital malformations. J Pediatr 72:790-795, 1968
12. Lorig K, Konkol L, Gonzalez V: Arthritis patient education: a review of the literature. Patient Educ Counsel 10:207-252, 1987
13. Mullen PD, Laville EA, Biddie AK, Lorig K: Efficacies of psychoeducational interventions on pain, depression, and disability in people with arthritis: a meta-analysis. J Rheumatol 14 (Suppl 15):33-39, 1987
14. Lorig KR, Mazonson PD, Holman HR: Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costs. Arthritis Rheum 36:439-446, 1993
15. Daltroy LH, Liang MH: Patient education in the rheumatic diseases: a research agenda. Arthritis Care Res 1: 161-169, 1988
16. Saag KG, Kolluri S, Koehnke RK, Georgou TA, Hunninghake GW, Schwartz DA: Rheumatoid arthritis lung disease: determinants of physiologic and radiographic abnormalities (abstract). Arthritis Rheum 38 (suppl 9): S364, 1995
17. Thurston NE, Watson LA, Reimer MA: Research or quality improvement? Making the decision. J Nurs Adm 23: 46-49, 1993
18. Hosmer DW, Lemeshow S: Applied Logistic Regression. New York, Wiley, 1989
19. Stewart RB, Claff LE: Review of medication errors and compliance in ambulatory patients. Clin Pharmacol Ther 13:463-465, 1972
20. Higbee M, Dukes G, Bosso J: Patient recall of physician's prescription instructions. Hosp Form 17:553-556, 1982
21. Katz JN, Daltroy LH, Brennan TA, Liang MH: Informed consent and the prescription of nonsteroidal antiinflammatory drugs. Arthritis Rheum 35:1257-1263, 1992
22. Jespersen D, Mahowald ML, Krug HE, Ytterberg SR: Patient knowledge of methotrexate: perception vs reality (abstract). Arthritis Rheum 37 (suppl 9):S429, 1994
23. Daltroy HL: Doctor-patient communication in rheumatological disorders. Baillieres Clin Rheumatol 7:221-239, 1993
24. Bond WS, Hussar DA: Detection methods and strategies for improving medication compliance. Am J Hosp Pharm 48:1978-1988, 1991
25. Heyduk LJ: Medication education: increasing patient compliance. J Psycho Soc Nurs Ment Health Serv 29: 32-35, 1991
26. Mazzuca SA: Does patient education in chronic disease have therapeutic value? J Chronic Dis 35:521-529, 1982